A Highly Heterogeneous HIV-1 Epidemic in the Central African Republic

Emerging Infectious Diseases

Volumn 2, Issue 3, 1996, Pages 222-224

  Massanga, Marcel ^a   Ndoyo, Justin ^a   Hu, Dale J ^b   Pau, Chou Pong ^b   Lee Thomas, Stephanie ^b   Hawkins, Reginald ^b   Senekian, Dominique ^a   Rayfield, Mark A ^b   George, J Richard ^b   Zengais, Amédée ^a   Yatere, Noel Ngalla ^a   Yossangang, Victor ^a   Samori, Aliou ^a   Schochetman, Gerald ^b   Dondero, Timothy J ^b  

^a Min de la S Pub et de la Pop   (Central African Republic)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL AFRICAN REPUBLIC; EPIDEMIC; EPIDEMIOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MALE; OUTPATIENT DEPARTMENT; PREGNANCY; PREVALENCE;

AMBULATORY CARE FACILITIES; CENTRAL AFRICAN REPUBLIC; DISEASE OUTBREAKS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PREGNANCY; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0030183439     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0203.960310     Document Type: Article

References (12)

1. Murphy E, Korber B, Georges-Courbot MC, You B, Pinter A, Cook D, et al. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic. AIDS Res Hum Retroviruses 1993;9:997-1006.
2. Mathiot CC, Lepage C, Chouaib E, Georges-Courbot MC, Georges AJ. HIV seroprevalence and male to female ratio in central Africa [letter]. Lancet 1990;335:672.
3. DeLeys R, Vanderborght B, Vanden Haesevelde M, Heyndrickx L, van Geel A, Wauters C, et al Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol 1990;64:1207-16.
4. Gurtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-5.
5. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Couroucé AM, et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-4.
6. Schable C, Zekeng L, Pau CP, Hu D, Kaptue L, Gurtler L, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994; 344:1333-4.
7. Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, Jaffe HW, et al. The emerging genetic diversity of HIV: the importance of global surveillance for diagnostics, research, and prevention. JAMA 1996; 275:210-6.
8. Slutkin G, Chin J, Tarantola D, Tarantola D, Mann J. Sentinel surveillance for HIV infection: a method to monitor HIV infection trends in population groups. WHO/GPA/DIR/88.8. Geneva: WHO, 1988.
9. Centers for Disease Control. Public Health Service guidelines for counseling and antibody testing to prevent HIV infections and AIDS. MMWR 1987;36:509-15.
10. Pau CP, Kai M, Holloman-Candal DL, Luo CC, Kalish ML, Schochetman G, et al. Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HTV vaccine sites. AIDS Res Human Retroviruses 1994;10:1369-77.
11. Pau CP, Hu DJ, Spruill C, Schable C, Lackritz E, Kai M, et al. Surveillance for HIV-1 Group O infections in the United States. Transfusion 1996;36:398-400.
12. Laga M, Nzila N, Goeman J. The interrelationship of sexually-transmitted diseases and HIV infection: implications for the control of both epidemics in Africa. AIDS 1991;5(suppl 1):S55-S63.